What the tablet’s labels say about the kidneys
None of the three documents lists stones, nephrolithiasis or urolithiasis [1][2][3]. They all carry a kidney warning, though, and it points in the same direction as stone prevention: fluid.
| Document | What it says | Link to stones |
|---|---|---|
| US Prescribing Information, section 5.5 [1] | Acute kidney injury, sometimes needing dialysis, mostly after nausea, vomiting or diarrhoea caused dehydration | Low fluid is the main stone risk too |
| US Medication Guide [1] | Drinking fluids helps reduce the chance of dehydration | Supports stone prevention |
| Canadian Patient Medication Information [3] | Drink plenty of fluids, especially if you have kidney problems | Supports stone prevention |
| US, EU and Canadian adverse-reaction sections [1][2][3] | No kidney stone or urinary stone entry | Not a recognised side effect |
A water rule that is easy to misread
Semaglutide tablets, Rybelsus® among them, are taken with a deliberately small amount of water. The US label says up to 4 ounces, Canada says no more than half a glass (120 mL), and Europe calls it a sip of up to 120 mL; Canada explains that a larger volume is likely to reduce how much semaglutide is absorbed [1][2][3]. After that, the label asks you to wait at least 30 minutes before eating or drinking [1].
That limit belongs to the tablet moment only. The same Medication Guide stresses drinking fluids to reduce the chance of dehydration, and the Canadian leaflet says to drink plenty, especially with kidney problems [1][3]. If you have had stones before, it is worth agreeing a daily fluid plan with your prescriber that starts after the 30-minute wait. Our page on Rybelsus® and the kidneys covers the injury warning in more detail.
What studies of semaglutide and GLP-1 medicines show
The clearest trial number comes from a different semaglutide product. In SELECT, a cardiovascular trial of injected semaglutide at the Wegovy® dose in people without diabetes, urolithiasis was reported in 1.2% on semaglutide against 0.8% on placebo, with serious cases in 0.6% against 0.4% [4]. The dose, route and population differ from Rybelsus®, so this cannot be transferred directly to the tablet.
A 2025 study of US Veterans Affairs records compared more than 215,000 people with diabetes starting GLP-1 medicines with over a million continuing usual care and found an increased risk of nephrolithiasis, along with gastrointestinal disorders and drug-induced pancreatitis [5]. Its abstract does not separate tablets from injections, and as an observational study it cannot rule out other differences between the groups. A 2025 Medicare study of 24-hour urine collections in people with stones and diabetes found no significant change in any stone-related urine measure with GLP-1 medicines [6].
For semaglutide tablets alone, a 2024 analysis of US FDA reports found 12 reports of kidney pain, a term reported more often than expected (reporting odds ratio 13.15) [7]. Kidney pain is a symptom rather than a diagnosis; it can come from stones, infection or other kidney problems, and spontaneous reports cannot establish cause or frequency.
How stones and the tablet could connect
- Supported by the label: nausea, vomiting and diarrhoea are the most common side effects, mainly while the dose is being increased, and can leave you short of fluid [1]. MedlinePlus says stones are more likely when you make less than 1 litre of urine a day [8].
- Proposed but not proven: eating less and changing what you eat can change urine composition; Cleveland Clinic lists protein-rich foods, salt, sugar and vitamin C supplements among dietary risk factors [10]. No Rybelsus® study has measured this.
- General medical knowledge: diabetes, obesity, gout and high blood pressure each raise stone risk on their own, so many people taking the tablet already have one or more risk factors [10].
Other reasons stones form
MedlinePlus explains that calcium stones, usually combined with oxalate, are the most common type, that struvite stones follow repeated urinary infections, and that uric acid stones are linked with gout [8]. Cleveland Clinic adds a family history, a blockage in the urinary tract, previous stomach or bowel surgery including gastric bypass, and some medicines such as certain diuretics and calcium-based antacids [10]. NIDDK notes that stones form when urine holds high levels of calcium, oxalate and phosphorus [9].
Telling stone pain apart from the label’s warnings
Stone pain is typically severe, starts and stops suddenly, sits in the side of the back or belly, and can move down towards the groin; blood in the urine, a constant need to urinate and pain on passing urine are common [8][9]. The Rybelsus® label carries two other abdominal warnings. Pancreatitis causes persistent, severe abdominal pain that may spread to the back, with or without vomiting, and gallbladder problems cause upper abdominal pain, sometimes with fever, yellow skin or eyes, or clay-coloured stools [1]. Because the patterns overlap, severe abdominal or back pain on Rybelsus® should be assessed rather than self-diagnosed.
For a stone that is expected to pass, MedlinePlus describes drinking plenty of water and notes that over-the-counter pain relievers such as ibuprofen or naproxen can be effective [8]. Ask your prescriber or pharmacist which pain relief suits your kidney function and other medicines, and remember that other tablets wait 30 minutes after Rybelsus® [1].
Rybelsus®, Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Unbearable side, back or groin pain | Emergency department | Emergency | Cleveland Clinic [10] |
| Severe abdominal pain that does not go away, possibly spreading to the back, with or without vomiting | Stop the tablets and call your prescriber right away; this may be pancreatitis | Emergency | Rybelsus® Medication Guide [1] |
| Flank or groin pain with fever or chills | Your health care provider right away | Today | NIDDK [9]; MedlinePlus [8] |
| Blood in the urine, pain on urinating, or being able to pass only a little urine | Your health care provider right away | Today | NIDDK [9] |
| Ongoing vomiting or diarrhoea with dark urine or passing much less urine | Your prescriber the same day | Today | Rybelsus® label [1] |
| A past kidney stone and starting Rybelsus® | Your prescriber, to agree a fluid plan | At your next appointment | Canadian leaflet [3]; MedlinePlus [8] |
